Clinical trial
Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain
NCT00281645 · DOV Pharmaceutical, Inc., Industry · Completed
Key facts
| NCT number | NCT00281645 |
|---|---|
| Title | Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain |
| Official title | A Multicenter Standard of Care-Controlled Study to Evaluate the Long-Term Safety of Bicifadine for the Treatment of Chronic Low Back Pain |
| Lead sponsor | DOV Pharmaceutical, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Low Back Pain |
| Intervention type | Drug |
| Interventions | Bicifadine, Standard of Care (pharmacological analgesic treatment) |
| Enrollment | 1,250 |
| Start date | Dec 1, 2004 |
| First posted | Jan 25, 2006 |
| Last update posted | Mar 27, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: